Navidea Biopharmaceuticals, Inc.

Industry

  • Biotechnology
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
    • Drug Delivery
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
      • Digital Imaging

Other Names/Subsidiaries

  • Macrophage Therapeutics
  • Neoprobe Corp.
See more in Biomedtracker

Latest on Navidea Biopharmaceuticals, Inc.

Scrip

Deal Watch: Japan’s SNBL To Re-Absorb US Spinout Satsuma

 
• By Joseph Haas, Lisa Takagi, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. SNBL To Pay 28% Premium To Re-Acquire S

Scrip

Deal Watch: RedHill Finds New Partner For Movantik

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. RedHill Sub-Licenses Some Rights To GI

Medtech Insight

Earnings Winners & Losers: The Large Diversified Firms, ABT, BAX, CAH, JNJ

 
• By Reed Miller

This edition of Medtech Insight 's Winners & Losers focuses on the medtech businesses of the big diversified medtech companies, including those that also operate in the pharmaceutical market. While c

Scrip

Norgine Builds Specialty Business In Europe From Canada's Merus Labs

 
• By John Davis

Norgine BV ’s acquisition of Canada’s Merus Labs International Inc. , which closed on July 17, 2017, is the largest to date for the privately held European specialty company, and the first involvi